ASC Stock Recent News

In the latest trading session, Ardmore Shipping (ASC) closed at $9.75, marking a -0.41% move from the previous day.

-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration. -As previously disclosed, oral tablet formulation of small molecule ASC30 demonstrated potentially best-in-class 6.3% weight loss in patients with obesity after a four-week treatment.

Ardmore Shipping Corporation (NYSE: ASC) trades almost at half its NAV, making it a prime takeover candidate with a 50% upside potential to $15.50 per share. The company has a modern fleet, low leverage, and strong financials, and recently started repurchases. Ardmore's low breakeven point and resilient operations position it to generate substantial profits, supported by favorable demand and supply dynamics in the MR segment.

In the closing of the recent trading day, Ardmore Shipping (ASC) stood at $10.08, denoting a +0.9% change from the preceding trading day.

Recently, Zacks.com users have been paying close attention to Ardmore Shipping (ASC). This makes it worthwhile to examine what the stock has in store.

Ardmore Shipping (ASC) concluded the recent trading session at $10.44, signifying a -0.67% move from its prior day's close.

Shares in ASOS PLC (LSE:ASC) jumped 13% on Thursday after the online fashion group's largest shareholder, Anders Holch Povlsen, upped his stake to over 28%. In a statement late the previous day, it was revealed that the Danish billionaire had upped his stake, via several vehicles, including his Bestseller retail chain, and two under the name of his father Troels Holch Povlsen, Holch Povlsen Switzerland and Nine United Properties UK.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

ASC47, an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity, demonstrated a half-life of up to 26 days and 40 days, respectively, in Phase Ib single subcutaneous injection studies in healthy subjects with elevated low-density lipoprotein cholesterol ( LDL-C) and patients with obesity, supporting once-monthly to once-bimonthly administration. ASC47 was safe and well tolerated in both healthy subjects with elevated LDL-C and patients with obesity.

Ardmore Shipping (ASC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.